HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637HAD1. A total of 64 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,745,527 | +20.6% | 6,769,000 | +18.7% | 0.13% | +45.7% |
| Q2 2023 | $4,764,400 | +29.7% | 5,702,000 | +32.3% | 0.09% | +33.3% |
| Q1 2023 | $3,674,305 | -77.8% | 4,310,000 | -74.6% | 0.07% | -76.0% |
| Q4 2022 | $16,543,125 | -34.1% | 17,000,000 | -42.4% | 0.29% | -36.9% |
| Q3 2022 | $25,112,000 | -2.7% | 29,500,000 | +1.4% | 0.46% | -0.4% |
| Q2 2022 | $25,812,000 | +1.9% | 29,094,000 | +0.8% | 0.46% | +12.8% |
| Q1 2022 | $25,319,000 | – | 28,859,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 70,776,482 | $60,420,911 | 4.46% |
| Lombard Odier Asset Management (Europe) Ltd | 41,798,000 | $35,110,320 | 1.74% |
| CAMDEN ASSET MANAGEMENT L P /CA | 47,123,000 | $39,937,073 | 1.34% |
| Penn Mutual Asset Management | 1,555,000 | $1,318,197 | 1.25% |
| DAVIDSON KEMPNER PARTNERS | 66,537,000 | $56,390,573 | 1.09% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 66,537,000 | $56,390,573 | 0.96% |
| ZAZOVE ASSOCIATES LLC | 9,443,000 | $8,011 | 0.73% |
| SHENKMAN CAPITAL MANAGEMENT INC | 8,934,000 | $7,582,430 | 0.58% |
| CSS LLC/IL | 8,000,000 | $6,788,288 | 0.45% |
| READYSTATE ASSET MANAGEMENT LP | 5,000,000 | $4,262,534 | 0.40% |